Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
Oh S, Yeom J, Cho HJ, Kim JH, Yoon SJ, Kim H, Sa JK, Ju S, Lee H, Oh MJ, Lee W, Kwon Y, Li H, Choi S, Han JH, Chang JH, Choi E, Kim J, Her NG, Kim SH, Kang SG, Paek E, Nam DH, Lee C, Kim HS.
Oh S, et al. Among authors: oh mj.
Nat Commun. 2020 Jul 3;11(1):3288. doi: 10.1038/s41467-020-17139-y.
Nat Commun. 2020.
PMID: 32620753
Free PMC article.